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Regulated blood production is achieved through the
hierarchical organization of dormant hematopoietic
stem cell (HSC) subsets that differ in self-renewal po-
tential and division frequency, with long-term (LT)-
HSCs dividing the least. The molecular mechanisms
underlying this variability in HSC division kinetics
are unknown. We report here that quiescence exit ki-
netics are differentially regulated within human HSC
subsets through the expression level of CDK6. LT-
HSCs lack CDK6 protein. Short-term (ST)-HSCs are
also quiescent but contain high CDK6 protein levels
that permit rapid cell cycle entry upon mitogenic
stimulation. Enforced CDK6 expression in LT-HSCs
shortens quiescence exit and confers competitive
advantage without impacting function. Computa-
tional modeling suggests that this independent
control of quiescence exit kinetics inherently limits
LT-HSC divisions and preserves the HSC pool to
ensure lifelong hematopoiesis. Thus, differential
expression of CDK6 underlies heterogeneity in
stem cell quiescence states that functionally regu-
lates this highly regenerative system.
INTRODUCTION
Hematopoiesis ensures that blood demand is met under homeo-
static and stress conditions through tightly controlled regulation
of hematopoietic stem cells (HSCs) and their progeny. HSCs are
historically identified by the unique capacity to self-renew,
providing long-term, serial reconstitution of the entire hemato-
poietic system upon their transplantation into myeloablated302 Cell Stem Cell 16, 302–313, March 5, 2015 ª2015 The Authorshosts. Functional self-renewal of HSCs is associated with
reduced cell cycle activity. Seminal papers demonstrated that
cell cycle becomes more frequent as HSCs gradually differen-
tiate into lineage-restricted progenitors (Bradford et al., 1997;
Morrison and Weissman, 1994; Pietrzyk et al., 1985; Suda
et al., 1983; Uchida et al., 2003). Although the HSC compartment
was thought to be heterogeneous in cycling ability (Micklem and
Ogden, 1976) 40 years ago, this has only recently been sup-
ported by experimental evidence as follows. (1) Label retaining
studies (Foudi et al., 2009; Qiu et al., 2014; Takizawa et al.,
2011; Wilson et al., 2008) conclusively established that the
HSC pool comprises at least two compartments differing in their
frequency of division. (2) The most dormant cells have the high-
est repopulation capacity and can be reversibly brought into cell
cycle through extrinsic cues, especially upon injury (Foudi et al.,
2009; Wilson et al., 2008). (3) The HSC pool has been fraction-
ated into long-term (LT-), intermediate-term (IT-), short-term
(ST-) HSCs and multipotent progenitors (MPPs) and is hierar-
chically organized based on progressively reduced repopulation
capacity and increased cycling properties (Benveniste et al.,
2010; Cheshier et al., 1999; Copley et al., 2012; Foudi
et al., 2009; Oguro et al., 2013; Passegue´ et al., 2005; Qiu
et al., 2014; Wilson et al., 2008). While the hierarchically orga-
nized HSC subsets are widely thought to prevent HSCs exhaus-
tion and preserve lifelong blood production, knowledge of the
molecular mechanisms that govern the variable cycling proper-
ties of each HSC subset is lacking.
Quiescence, defined as a reversible absence of cycling, also
called G0, is a defining feature of HSCs first described in Lajtha
(1963). Most transgenic and knockout mouse models altering
HSC function decrease quiescence, leading to HSC exhaustion
(reviewed in Pietras et al., 2011; Rossi et al., 2012). Quiescence
and infrequent cycling of HSCs are considered to protect against
damage accumulation, and impaired maintenance of HSC
quiescence is thought to contribute to aging and leukemia.
However, understanding how HSCs switch from quiescence to
cycling and how division, self-renewal, and differentiation are in-
tegrated is lacking.
Upon reception of mitogenic signals, multiple processes must
occur: HSCs must exit quiescence to enter the cell cycle, which
then must be traversed to complete a division. This requires re-
activating all the necessary metabolic and cell cycle machinery.
Doubling time analysis at homeostasis has shown that ST-HSCs
and MPPs divide more frequently than LT-HSCs (Foudi et al.,
2009; Oguro et al., 2013; Wilson et al., 2008). Little is known
about quiescence exit. It is unclear if and how it is differentially
regulated among distinct HSC subsets and if the duration of
this exit affects HSC function. We recently showed that the dura-
tion of a division starting fromG0 after stimulation by a mitogenic
signal is shorter in IT-HSCs than in LT-HSCs (Benveniste et al.,
2010). The unknown mechanism underlying increased cycling
in IT/ST-HSCs could theoretically be due to (1) easier activation
from external stimuli, (2) less time in G0, (3) faster exit from quies-
cence, (4) faster completion of divisions, or (5) a combination of
these. An integrated view is necessary to ascertain how these
properties in HSC subsets are molecularly regulated. Here, we
establish that the duration of HSC exit from quiescence upon
mitogenic stimulation is differentially regulated within the human
HSC pool by a CDK6-primed quiescence state in ST-HSCs.
Tight control of quiescence exit length via CDK6 levels plays
an important role in HSC pool dynamics, preserving integrity
and preventing LT-HSCs clonal expansion.
RESULTS
Heterogeneity in the Human HSC Pool
The cycling properties of mouse HSC subpopulations are
described, but they have not been validated in the human HSC
hierarchy. Human LT-HSCs, isolated from umbilical cord blood
(CB) as Lin CD34+ CD38 CD45RA CD90+ CD49f+ (Notta
et al., 2011), provide robust multilineage repopulation beyond
30weeks in the NSGmouse xenograft assaywith about 10% fre-
quency (Notta et al., 2011) and efficiently engraft upon second-
ary transplantation (Table S1). In contrast, Lin CD34+ CD38
CD45RA CD90 CD49f cells generate multilineage grafts
over intermediate time periods (Notta et al., 2011), but they
lack serial transplantation ability and thus have limited self-
renewal (Table S1). According to the criteria used in mouse,
this population corresponds to ST-HSCs. Importantly, LT- and
ST-HSC-enriched populations can be purified with the cell sur-
face markers indicated above from NSG mice repopulated with
human cells (Table S1). Similar to transplantation models in
mice, phenotypic human LT- and ST-HSCs expand in the first
4 weeks after xenotransplant (with >50% that actively cycle)
then regain quiescence by 20 weeks when a transient equilib-
rium phase is reached (Figures 1A, S1A, and S1B). In our model,
functionally repopulating LT-HSCs expanded z30-fold in
20 weeks (Figure 1B).
To estimate the division frequency of human HSC subsets, we
tracked BrdU incorporation kinetics of phenotypic LT- and ST-
HSCs in xenografts and observed, similarly to mouse models,
that phenotypic LT-HSCs divide less frequently (1.5- to 1.9-
fold) than phenotypic ST-HSCs (Figure 1C), whether in expan-
sion or at equilibrium. Although both subsets highly proliferate
after transplantation, we detected fewer ST-HSCs, possiblyCbecause of their higher drive to produce differentiated cells
(Figure 1A). To capture a core signature of genes distinguishing
LT- from ST-HSCs, we subjected LT- and ST-HSCs isolated
from CB and at different times after xenotransplantation to tran-
scriptome analysis. Using the Bayesian Estimation of Temporal
Regulation algorithm (Aryee et al., 2009), we identified 241 genes
showing sustained differential expression between LT- and
ST-HSCs independent of environmental effects and changes in
proliferation (Table S2 and Figures S1C–S1E). This was signifi-
cantly more than in our previous static analyses of CB (Laurenti
et al., 2013; Notta et al., 2011). This signature contains genes
important in murine HSC function (Gazit et al., 2013; Jankovic
et al., 2007; Kataoka et al., 2011; Laurenti et al., 2008) (Figure 1D)
and is enriched for gene ontology terms related to the
immune/inflammatory response, chromatin remodeling, and
most significantly, cell cycle regulation (Figure 1E). Thus, human
ST-HSCs, similar to mouse, have lower repopulation capacity,
more frequent divisions, and a distinct transcriptional profile
compared to LT-HSCs.
LT-HSCs and ST-HSCs Are Equally Quiescent
The increased frequency of ST-HSC divisions may be due to (1)
more cells actively cycling at any time, (2) increased sensitivity,
or (3) faster response tomitogenic stimulation. To resolve the ba-
sis for these increased divisions, we investigated the proportions
of LT- and ST-HSCs in each cell cycle phase and found them to
be identical at all points during the xenotransplantation process
(Figure S1B). Freshly isolated from CB, both HSC subsets had
more than 90% of cells in G0 (Ki67
 2n DNA content, Figures
2A and 2B). Importantly, no cell was found in S-G2-M as deter-
mined by DNA content (Figures 2A and 2B) and by complete
absence of the mitotic marker phosphoH3 (Figure S2A). Cell di-
ameters were equally small in LT- and ST-HSCs (Figure 2C), with
both lacking in cytoplasm. Metabolically, both LT- and ST-HSCs
showed low mitochondrial activity (Figure 2D) and similar levels
of mTOR activation (assessed by phosphoS6 staining; Fig-
ure 2E). All these parameters indicate a G0 quiescent state. To
exclude a possible differential G1 arrest state for LT- and ST-
HSCs, we analyzed the phosphorylation state of retinoblastoma
protein (RB) at S807/S811, a marker upregulated in G0 cells
before entry into G1 (Ren and Rollins, 2004). Both cell types
were negative (Figures 2F and S2B). In contrast, granulocyte-
monocyte progenitors (GMPs) were largely in G1, as most cells
were Ki67+ with 2n DNA content (Figure 2B) and had a larger
diameter (Figure 2C), visible cytoplasm, increased mitochondrial
activity (Figure 2D), and RB phosphorylation on S807/S811 (Fig-
ure 2F). Collectively, these data establish that both human LT-
and ST-HSCs freshly isolated from CB reside in a G0 quiescent
state lacking all markers of G1.
Distinct Cell Division Durations in HSC Subsets
Since the proportions of LT- and ST-HSCs in G0 were identical
(Figures 2B and S1B), we hypothesized that the differences
in expression of cell cycle genes and frequency of division
observedbetween these twosubsets reflecteddifferences in their
capacity to exit quiescence upon mitogenic stimulation. There-
fore, we measured the duration of single divisions occurring
upon activation by a mitogenic signal. Such studies need to be
performed with single cells using in vitro assays. We sorted 576ell Stem Cell 16, 302–313, March 5, 2015 ª2015 The Authors 303
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Figure 1. Human HSC Subsets in the Xeno-
graft Divide with Distinct Frequencies and
Display Distinct Transcriptional Profiles
(A) Number of cells per mouse of indicated pop-
ulations in the bone marrow of the mice at indi-
cated time points post-transplantation of 70,000
Lin CB (saturating number of LT-HSCs). Median
and interquantile ranges are shown. ***p < 0.01 by
one-way ANOVA and Tukey test.
(B) The number of repopulating LT-HSCs per
mouse at indicated time points post-trans-
plantation were calculated by multiplying the
number of phenotypic LT-HSCs shown in (A) by
the frequency of long-term repopulating cells
indicated in Table S1.
(C) BrdU incorporation kinetics over 12 days of
LT-HSC (black) and ST-HSC (red) enriched pop-
ulations isolated from pools of two to five mice
engrafted with 70,000 Lin CB cells. BrdU was
started either at 4 (left panel, expanding phase) or
20 weeks post-transplantation (right panel, equi-
librium phase). n = 1–4 pools of three to five mice
from six (4 weeks) or one (20 weeks) independent
CB samples. Curve is least-squares fit. Left panel:
R2 > 0.96; right panel: R2 > 0.98. Doubling times
(half times of fit) in hours are shown in the insert.
***p < 0.01 by extra-sum of squares test.
(D and E) Derivation of a 241-gene signature dis-
tinguishing LT- and ST-HSCs in unperturbed CB
over 20 weeks in a xenotransplant. (D) Examples
of five expression profiles of genes with known
HSC function over the course of 20 weeks of xe-
notransplant (black: LT-HSCs, red: ST-HSCs),
mean ± S.E.M shown, n = 3 per time point. (E)
Selected gene ontology terms significantly en-
riched in the 241-gene LT-HSC/ST-HSC core
signature. Shown is the log10 of the Benjamini-
Hochberg adjusted p value.
See also Figure S1.single LT- and ST-HSCs from CB and monitored their divisions
over 140 hr in serum-free conditions. As expected, proliferation
was higher in ST-HSCs (Figure S2C). The mean time to first divi-
sion (tFirstDiv) varied between CB samples, but on average it was
9 hr shorter in ST-HSCs compared to LT-HSCs (Figures 2G and304 Cell Stem Cell 16, 302–313, March 5, 2015 ª2015 The Authors2H). The mean time to second division
(tSecondDiv = tG1-S-G2-M) was also signifi-
cantly shorter in ST-HSCs than in LT-
HSCs (Figures 2I and S2D). Importantly
the second division was always shorter
than the first, identifying a latency
restricted to HSCs that transition out
from a non-stimulated quiescent state. In
contrast to in vivo repopulation, cells in
this assay do not return to G0 after
division (Figure S2E). Therefore, the la-
tency phenomenon observed in the first
division encompasses the events pertain-
ing to the G0 to G1 transition but may
also include portions of early G1. For
simplicity, it will be hereafter called ‘‘G0
exit,’’ and calculated as tFirstDiv – tSecondDiv.By this analysis, LT-HSCs egressed fromG0 less rapidly than ST-
HSCs on average by 5.8 hr (Figure 2J). Similar results with slower
kinetics were obtained when single LT- and ST-HSCs were
cultured in a medium with lower cytokine and nutrient concentra-
tions (Figures S2F and S2G). These parameters are not unique to
ALT-HSC
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Figure 2. LT- and ST-HSCs Are Equally Quiescent, but upon Mitogenic Stimulation They Differ in the Duration of Divisions Starting from
G0 or G1
(A and B) Proportion of human CBHSC and progenitor cells in each phase of the cell cycle. Parameters were assessed by flow cytometry using Ki67 and Hoechst
(Ki67 2n DNA content, G0; Ki67
+ 2n DNA content, G1; Ki67
+ > 2n DNA content, S-G2-M). (A) Representative flow cytometry cell cycle profiles of CB LT- and ST-
HSCs and the percentage of cells in each gate. Event count: LT-HSCs (top panel), 1,320 cells; ST-HSCs (bottom panel), 1,143 cells. (B) Mean ± SEM is shown;
n = 3 CB samples.
(C) Cell diameter of indicated populations measured with ImageJ from microscopy pictures. n > 323 cells from four independent CB samples.
(D) Mitochondrial mass asmeasured by flow cytometry withMitoGreen. MFI, Mean Fluorescence Intensity; mean ± S.E.M shown, n = 2 independent CB samples.
(E) PhosphoS6 protein levels as measured by flow cytometry. Left panels: representative flow cytometry plots; black line, LT-HSCs; red line, ST-HSCs. Right
panel: median fluorescence intensity of phosphoS6 staining. Mean ± SEM is shown. n = 2 CB samples.
(F) Percentage of cells positive for phosphoRB (S807/S811) as measured by flow cytometry; mean ± S.E.M shown, n = 2 independent CB samples. GMP,
granulocyte-monocyte progenitors.
(G) Cumulative first division kinetics (excluding dead cells) of LT-HSCs (black) and ST-HSCs (red) from a representative CB example. Curve is least-squares
sigmoid fit. R2 > 0.99. Arrowheads represent time to first division as estimated from sigmoid fit (tFirstDiv = logEC50). Time 0 is the time of exposure to mitogenic
stimulus.
(H) Mean time to first division (in hours).
(I) Mean time of cell cycle transit (tSecondDiv = logEC50 of sigmoid fit of cumulative second division kinetics; see Figure S2E).
(J) Mean time of G0 exit (in hours) (tG0exit = tFirstDiv – tSecondDiv).
In (H)–(J), individual CB samples are shown; gray lines connect LT-HSC and ST-HSC parameters from the same CB. **p < 0.05, ***p < 0.01 by paired t test. See
also Figure S2.CB: fully quiescent LT-HSCs isolated from adult bone marrow
also displayed a significant delay in G0 exit compared to ST-
HSCs (Figure S2H). Collectively, upon stimulation by mitogenicCsignals, the duration of a division is consistently shorter in human
ST-HSCs than in LT-HSCs, whether cells need to transition out of
quiescence or continuously cycle.ell Stem Cell 16, 302–313, March 5, 2015 ª2015 The Authors 305
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Figure 3. Distinct CDK6 Levels Govern the G0 Exit Kinetics of LT- and ST-HSCs
(A) Log2 signal intensity for CDK6mRNA probe. Shown are individual measures (black circles: LT-HSCs, red squares: ST-HSCs, green triangles: GMPs) and the
median and interquantile ranges (horizontal bars); n = 3. All multiple comparisons have been tested.
(B) Immunofluorescence for CDK6 protein in LT- and ST-HSCs sorted from CB (left panel) or cultured for 4 days (right panel). Representative pictures and
histograms of CDK6 fluorescence density are normalized to the fluorescence density of the IgG control in the same population. Positivity threshold was set over
the median + 1 SD of the IgG control distribution and the percetnage of positive cells is indicated. 100–570 cells are analyzed with n = 3 CB samples. Scale bar
represents 10 mM.
(C) Normalized median CDK6 fluorescence density. Mean ± SEM is shown; n = 3 CB samples. GMPs, granulocyte-monocyte progenitors.
(D) Immunofluorescence for CyclinD3 protein in LT-HSCs, ST-HSCs, and GMPs from freshly isolated CB (Day 0, left panel) or after 4 days of culture (Day 4, right
panel). Shown are histograms of CyclinD3 fluorescence density normalized to the fluorescence density of the IgG control in the same population. Positivity
threshold (dotted line) was set over the median + 1 SD of the IgG control distribution. n = 135–315 cells analyzed for day 0 and n = 49–245 cells for day 4.
(E) Normalized median CyclinD3 fluorescence density at the indicated time points. Mean ± SEM is shown; n = 3 CB samples. **p < 0.05 by paired t test.
(F) Time course analysis of CDK6 and CyclinD3 upon stimulation bymitogenic signals. Percentages of CDK6+ (top panel) or CyclinD3+ (bottom panel) cells in each
of the indicated populations at the indicated time points after isolation from CB are shown. Mean ± S.E.M shown. n = 3 CB samples, except for day 2, where n = 2
CB samples. **p < 0.05 by paired t test.
See also Figure S3.Distinct Expression of CDK6 Protein in the Quiescent
HSC Pool
To identify the molecular determinants underlying differences in
the duration of LT- and ST-HSC divisions, we screened the 241-
gene core signature for genes known to be involved in either G0
exit or G1 progression. CDK6 was selected because its mRNA306 Cell Stem Cell 16, 302–313, March 5, 2015 ª2015 The Authorswas consistently upregulated in ST-HSCs both in CB and upon
xenotransplantation (Figures 3A, S3A, and S3B), and CDK6/Cy-
clinD complexes regulate G0 exit and early G1 (Sherr and Rob-
erts, 2004). Importantly, the CDK6 protein was undetectable in
most of the quiescent CB LT-HSCs, but it was upregulated after
4 days of culture when all HSC subsets actively cycle (Figures 3B
and 3C). In sharp contrast, before culture, ST-HSCs already ex-
pressed high levels of CDK6 protein, similar to that found in G1
GMPs, despite being quiescent (Figures 3B, 3C, and S3C). Simi-
larly, adult ST-HSCs isolated from either bone marrow or mobi-
lized peripheral blood also expressed high levels of CDK6,
though it was undetectable in adult LT-HSCs (Figures S3D–
S3F). To gain insight into how ST-HSCs can remain quiescent
with high levels of CDK6 protein, and because CDK6 kinase ac-
tivity depends on its association with CyclinD proteins, we exam-
ined the levels of CyclinD1 and CyclinD3 protein in sorted LT-
and ST-HSC subsets from purified CB at day 0. We found that
neither one expressed CyclinD1 nor CyclinD3; as expected,
both were expressed in G1 GMPs (Figures S3G, S3H, 3D, and
3E). Therefore the CDK6 in ST-HSCs is not part of an active com-
plex, which explains the absence of RB phosphorylation in these
cells (Figure 2F) and their quiescence. To gain insight into how
the CyclinD-CDK6 complexes integrate proliferative signals
once HSCs are activated, we did a time course analysis of
CDK6, CyclinD1, and CyclinD3 protein expression. After
2 days of culture, less than 5% of LT- and ST-HSCs divided (Fig-
ure 2G). Interestingly, about 54% of LT-HSCs expressed CDK6
and 44% and 25% express CyclinD1 and CyclinD3, respectively
(Figures S3H and 3F). In contrast, almost all ST-HSCs had upre-
gulated CyclinD3 protein by day 2, and 52% express CyclinD1.
By day 4, when all LT- and ST-HSCs actively cycle (Figure 2G),
each HSC subset expresses both CDK6 and CyclinD3 proteins
(Figure 3F). These data indicate that, upon activation by mito-
gens, the assembly of the CDK/CyclinD complex is more rapid
and more robust in ST-HSCs than in LT-HSCs. Overall, these
data reveal two unexpected findings. First, ST-HSCs exist in a
G0 state, yet they express a known driver of G1 progression
(CDK6) while lacking the cognate partners (CyclinD1 and
CyclinD3) of CDK6. Second, the hierarchical organization based
on functional repopulation properties also exhibits a hierarchy of
CDK6/CyclinD complex components reflecting distinct cycling
properties: LT-HSCs are negative for both CDK6 and CyclinD;
ST-HSCs express exclusively CDK6; and lineage-restricted pro-
genitors, e.g., GMPs, express both.
CDK6 Levels Regulate the Duration of G0 Exit
To gain mechanistic insight into the correlation between CDK6
protein levels and cell division duration within HSC subsets, we
altered CDK6 levels and investigated the effect on the kinetics
of the first HSC division. To examine loss of function, we
measured the duration of cell division when single LT- and ST-
HSCs are exposed to a mitogenic stimulus in the presence of
the highly specific CDK4-CDK6 inhibitor PD033299. Themajority
of LT-HSCs never divided in the presence of PD033299 (Fig-
ure 4A). Similarly there was a strong reduction in the number of
ST-HSCs that could divide (Figure 4A). However, for those ST-
HSCs that divided, inhibition of CDK6 brought the length of the
first division to that of LT-HSCs (Figures 4B and 4C). Intriguingly,
those 10% LT-HSCs dividing in the presence of PD033299 were
not further delayed, potentially representing a subset of more
‘‘activated’’ cells within the LT-HSC phenotypic compartment.
To examine the consequences of CDK6 gain of function, we en-
forced expression of CDK6 protein (CDK6 EE) with lentiviral vec-
tors in LT- and ST-HSCs before their first division (Figures S4A
and S4B). CDK6 EE did not change any ST-HSC cell cycle pa-Crameters (Figures 4D–4F, S4C, and S4E). By contrast, a division
starting from G0 (first division) of CDK6 EE LT-HSCs was signif-
icantly shortened to values similar to those of ST-HSCs (Figures
4D and 4E); control transduced LT-HSCs (LUC) showed no such
changes. CDK6 EE did not decrease the duration of a division
starting from G1 that remained significantly longer than that of
ST-HSCs (Figures 4F, S4C, and S4F). Also, CDK6 EE did not
affect the long-term proliferative output of LT-HSCs in vitro in
conditions where cells do not return to G0 (Figure 4G). These ap-
proaches show that CDK6 shortens divisions starting from G0,
but not divisions starting from G1. Moreover, variation in CDK6
protein levels between HSC subsets results in active regulation
of the duration of the latency that is unique to HSCs transiting
out of G0, a process we define as G0 exit. Importantly, our data
also establish that pre-existent CDK6 in ST-HSCs primes them
for earlier cell division upon mitogenic stimuli.
CDK6 EE Confers a Competitive Advantage to LT-HSCs
without Exhaustion
In mouse models, failure to maintain quiescence and/or
increased cycling are mostly associated with decreased self-
renewal and eventual HSC exhaustion (Orford and Scadden,
2008; Pietras et al., 2011; Rossi et al., 2012). To examine the
long-term effect of exclusively accelerating the duration of exit
from quiescence upon reception of mitogenic stimuli, we en-
forced CDK6 expression in LT-HSCs in vivo, where HSCs return
to G0 after most divisions under homeostatic conditions (Wilson
et al., 2008 and Figure S1B). Competitive xenotransplantation
experiments showed that CDK6 EE does not confer a prolifera-
tive advantage within the first 4 weeks post-transplantation, dur-
ing which HSCs are actively cycling (Figure 5A). However, by
20weeks post-transplantation, most HSCs have regained quies-
cence. At this point, CDK6EE cells, unlike LUC cells, significantly
outcompete untransduced cells (median GFP+ percentage:
LUC, 59.4%; CDK6 EE, 76.2%, p = 0.007, Figure 5A) without dis-
playing any lineage bias (Figures 5B and S5A). This expansion
originated from LT-HSCs (Figures 5C and 5D) and extended to
all progenitor populations (Figure S5B). To determine whether
the CDK6 EE in phenotypic LT-HSCs altered serial repopulating
capacity, secondary transplantation was performed. There was
no significant difference in the graft size at 12 weeks after sec-
ondary transplantation when high numbers of control (LUC/
GFP) and CDK6 EE LT-HSCs were transplanted (Figures 5E
and S5C). However, limiting dilution analysis revealed a 4-fold in-
crease in the frequency of repopulating LT-HSCs in the CDK6 EE
group compared to controls (Figure 5F), confirming LT-HSC
expansion over two rounds of transplantation. Importantly, like
our in vitro results, CDK6 EE did not change the rate of cell cycle
transit of LT- or ST-HSCs (Figure S5D) but accelerated the first
division of LT-HSCs (Figure S5E). These data show that the
unique shortening in the duration of G0 exit conferred by CDK6
EE gives LT-HSCs a competitive advantage without altering
self-renewal or differentiation abilities.
Simulating the Impact of G0 Exit Durations on
Hematopoietic Homeostasis
Our data show that upon activation, LT-HSCs are delayed in
their quiescence exit. Because LT-HSCs have been estimated
to divide very infrequently, approximately once every 135 andell Stem Cell 16, 302–313, March 5, 2015 ª2015 The Authors 307
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Figure 4. CDK6 Levels Determine the Duration of Quiescence Exit in the HSC Pool
(A–C) Cell division duration of single LT- and ST-HSCs after exposure tomitogenic signal in the presence or absence of PD033299 (50 nM). (A) Percentage of cells
from the indicated populations that divided after 100 hr in culture. (B) Cumulative first division kinetics (excluding dead cells). Data from a representative CB
example are shown. Curve is least-squares sigmoid fit. R2 > 0.99. (C) Mean time to first division (hours) (tfirstDiv = logEC50).
(D–G) Cell division duration of single LT- and ST-HSCs after exposure tomitogenic signal with or without CDK6 EE. (D) Cumulative first division kinetics (excluding
dead cells) of indicated populations transducedwith indicated lentiviral vectors. Data from a representative CB are shown. Curve is least-squares sigmoid fit. R2 >
0.99. (E) Mean time to first division (hours) (tfirstDiv = logEC50). (F) Time of cell cycle transit of indicated populations in hours.
(G) Expansion curves of LT- and ST-HSCs in culture. Shown is the average number of cells per single cell plated at the indicated time points after culture initiation.
Data are from one representative experiment out of three. Time 0 represents the time of exposure to mitogenic stimulus.
In (A), (C), (E), and (F), individual CB samples are shown; gray lines connect parameters from the same condition. **p < 0.05 by paired t test. See also Figure S4.280 days in mouse and human, respectively (Catlin et al., 2011;
Wilson et al., 2008), we sought to quantify consequences of this
delay to cell cycle entry in homeostatic conditions. Because it is
impossible to experimentally examine homeostatic human HSC
pool dynamics over long periods, we turned to computational
modeling. Our data strongly suggest that control of cell division
is achieved through regulation of quiescence exit and cell cycle
transit as two discrete steps. We established an agent-based
model to investigate (1) the consequences of independent con-
trol of the duration of quiescence exit and (2) the effect of the
5.8 hr delay in LT-HSC quiescence exit. In this model, the main-
tenance of the number of cells in the system is controlled in a
closed loop, and dynamic properties of the model—how often308 Cell Stem Cell 16, 302–313, March 5, 2015 ª2015 The Authorscells divide and how quick the response to injury—arise purely
from the different durations of the stages of cell division (Fig-
ure S6A). All parameters and assumptions of the model are
reported in the Supplemental Experimental Procedures. Most
parameters, in particular the division times (mean ± SD), were
measured experimentally. When not possible (i.e., HSC pool
exit rate and noise), we tested the full range of possible values
(discussed in the Supplemental Experimental Procedures) and
chose those predicting a number of HSC divisions per year
that is in the range reported in the literature for human HSCs
(Catlin et al., 2011) (Figures S6B–S6G).With this set of physiolog-
ically relevant parameters, we investigated the outcome of (1) a
control situation in which division is controlled with one kinetic
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Figure 5. CDK6 EE LT-HSCs Outcompete Wild-Type HSCs without Exhaustion
(A–D) NSG mice were injected with sorted Lin CD34+ CD38 cells transduced with CDK6 EE or control (LUC) lentiviral vectors (GFP+ cells) and untransduced
competitive cells (GFP). Bonemarrowwas harvested at indicated time points post-transplantation and analyzed by flow cytometry. (A) Percentage of GFP+ cells
among engrafted human hematopoietic cells (CD45+). Time 0 corresponds to percentage of GFP+ cells before injection in four independent CB samples. 4 weeks
post-transplantation: n = 13 LUC and 14 CDK6 EE mice; 20 weeks post-transplantation: n = 25 LUC and 23 CDK6 EE mice. (B) Lymphoid to myeloid ratio
(percentage of CD19+/CD33+) among GFP+ cells at 20 weeks post-transplantation. n = 25 LUC and 23 CDK6 EE mice. In (A) and (B), boxplots represent median,
25th, and 75th percentiles and whiskers represent min and max. Gray boxes, LUC; white boxes, CDK6 EE. (C) Percentage of GFP+ cells among LT-HSCs at
20 weeks post-transplantation. (D) Absolute number of LT-HSCs at 20 weeks post-transplantation. In (C) and (D), n = 6 mice from two CB samples. Individual
mice, median, and interquantile range are shown. In (A)–(D), *p < 0.1, **p < 0.05, ***p < 0.01 by Mann-Whitney test.
(E and F) CDK6 EE LT-HSCs expand over serial transplantation. LUC, CDK6 EE (GFP+), or untransduced (GFP) LT-HSCs were sorted from primary transplanted
mice (n = 2 pools of three to five mice) and injected at four different doses into secondary NSGmice. (E) Engraftment levels (percentage of CD45+ cells) 12 weeks
after secondary transplantation (>0.01% CD45+ GFP+ or CD45+ GFP) at the two highest doses (200 and 400 cells/mouse). Individual mice, median, and in-
terquantile range are shown. (F) Summary table of number of mice engrafted at each dose tested and estimation of LT-HSC frequencies in each group by the
ELDA statistical method. See also Figure S5.parameter (from reception of signal to the generation of two
daughter cells, with cells committed to divide upon sensing the
signal), and (2) a situation in which quiescence exit and cell cycle
transit are controlled independently, and where commitment to
division happens only once the cell has transitioned out of the
quiescence exit phase (Figure 6A). We invariably found that the
number of LT-HSC divisions is lower when the duration of a
cell division starting from G0 is defined by two independent ki-
netic parameters (quiescence exit and cell cycle transit) rather
than a single parameter describing the average division time
(Figures 6B and 6C). Furthermore, the overall number of LT-
HSC divisions simulated to occur over 1 year was again
decreased with a 5.8 hr delay in LT-HSC tG0 exit (Figures 6B
and 6C). In fact, a delay as short as 2.6 hr was sufficient to signif-
icantly spare the number of LT-HSC divisions (Figure 6D). In
addition, in response to perturbation such as might be experi-
enced under hematopoietic stress, the rate of recovery in the
HSC and progenitor pools was considerably improved by regu-
lation through two kinetic parameters and even further when the
delay in tG0 exit in LT-HSCs was included (Figures 6E, S6H, andCS6I). Our model thus demonstrates that the ability to modulate
the length of G0 exit independently of changes in duration of
cell cycle transit provides better robustness to homeostatic
and stress response hematopoiesis. Importantly, a delay in the
duration of G0 exit in LT-HSCs compared to ST-HSCs leads to
further optimization, indicating that regulation of the duration of
the G0 exit phase rather than that of a whole division is key to
controlling HSC pool maintenance and hematopoietic system
responses.
DISCUSSION
Our study provides key insights into the regulation of cycling
within the HSC pool and furthers our understanding of quies-
cence. We establish that the level of CDK6 functions as a master
regulator of the duration of quiescence exit. CDK6 is differentially
regulated at the transcriptional and post-transcriptional level in
HSC subsets. In particular, the absence of CDK6 protein in LT-
HSCs results in a 5–6 hr delay to G0 exit. The cumulative effect
of this delay limits LT-HSC divisions and ultimately preservesell Stem Cell 16, 302–313, March 5, 2015 ª2015 The Authors 309
AB C D
E
Figure 6. Simulation of the Impact of De-
layed G0 Exit in LT-HSCs on the HSC Pool
with an Agent-Based Model
(A) Comparison between the three hypotheses
tested by the modeling strategy. Earlier modeling
strategies of homeostasis assumed that all HSCs
started division upon receiving a mitogenic signal
with one characteristic cycling time per HSC
subtype (HYP. 1). Rather, we propose that G0 exit
and cell cycle progression are differentially and
independently regulated. This results in two char-
acteristic cycling times per HSC subtype without
(HYP. 2.1) or with (HYP. 2.2) a delay in G0 exit
between LT- and ST-HSCs. Cycling times indi-
cated are asmeasured in Figures 2G–2J. (B and C)
Simulated number of LT-HSC divisions per year in
the HSC pool at homeostasis (B) and after
perturbation (C). (D) Effect of changing the LT-HSC
G0 exit delay parameter on the number of LT-HSC
divisions. Shown is the number of divisions in the
LT-HSC pool per year when the delay of G0 exit of
LT-HSCs (compared to ST-HSCs) is inputted at
0 (no delay), 2.9, 5.8 (experimental value), or
11.6 hr. (E) Perturbation model: 1% of the pro-
genitor compartment was eliminated at the time
indicated by an arrow to simulate injury. Number of
progenitor cells (left panel), ST-HSCs (middle
panel), and LT-HSCs (right panel) are displayed as
a function of time. In (B)–(E), data represent the
mean ± SD of 256 runs. The simulations were run
with a noise parameter of 5% and an HSC pool exit
rate of 24 cells per day. How parameters were
chosen and results with different parameters are
shown in Figure S6 and discussed in the Supple-
mental Experimental Procedures.HSC pool integrity in the long term. Because human HSC
possess unique mechanisms to prevent propagation when
damaged (van Galen et al., 2014; Milyavsky et al., 2010), we
speculate that delayed G0 exit may also be crucial to coordinate
repair and LT-HSC fate choices upon their exposure to stress.
In line with the importance of the relative levels of the CyclinD-
CDK partners in mediating cell cycle entry and progression
(Sherr and Roberts, 2004), our data indicate that the presence
of CDK6 in ST-HSC is sufficient to place these cells in the ‘‘start-
ing blocks’’ for division upon mitogenic signaling. Production
and activation of CyclinD-CDK complexes is gradual and in-
volves many levels of regulation including gene transcription,310 Cell Stem Cell 16, 302–313, March 5, 2015 ª2015 The Authorsprotein stability, assembly, and nuclear
import (Sherr and Roberts, 2004). Consis-
tent with our results a recent study found
that a constitutive knockout of CDK6
does not affect HSCs in homeostasis,
but their activation in vivo by mitogenic
signals such as 5-FU or IFN is prevented
(Scheicher et al., 2014). In line with what
is seen in HSCs, memory T cells segre-
gate fully formed CyclinD3/CDK6 com-
plexes in their cytoplasm, which, upon
antigen stimulation, allow them to enter
cell cycle faster than naive T cells whereinboth CDK6 and CyclinD3 are expressed at much lower levels
(Veiga-Fernandes and Rocha, 2004). Together, these findings
support a model in which any molecular configuration that puts
cells closer to an active CDK/CyclinD complex is likely to result
in faster cell cycle entry/G0 exit. Our data further indicate that
deeper (LT-HSCs) and shallower (ST-HSCs) states of quies-
cence are an embedded feature of the hematopoietic hierarchy
at homeostasis. Furthermore, the CDK6-primed G0 state of
ST-HSCs does not overlap with Galert, a recently described
injury-stimulus-induced adaptive mechanism that positions
stem cells to rapidly respond to further stress by activating the
mTORC1 pathway (Rodgers et al., 2014). We found that
homeostatic ST-HSCs display similar levels of mitochondrial
and mTORC activity to that of LT-HSCs, indicating that they
are not in Galert. Rather, the injury-independent pre-existent
diversity in quiescent states that we report coexists with, and
is upstream of, Galert.
In a high output system like blood, which is sustained by a
limited number of active HSCs, a number of theoretical frame-
works describe how HSC heterogeneity, notably in division
rates, contributes to lifelongmaintenance of hematopoiesis. Pre-
vious modeling strategies (Glauche et al., 2009; Hoffmann et al.,
2008; Roeder and Loeffler, 2002) describe the division properties
of HSCs by a single, unique parameter that is usually derived
from average division frequencies and thus includes the time
spent in G0 plus the time from the reception of the signal to the
end of division. In contrast to these prior studies, we explicitly
model the control of the duration of cell division from the time
of the mitogenic signal, using a computational model where
the signal is automatically generated depending on needs. This
framework allows investigation of which division duration control
strategy better preserves HSC pool integrity and maximizes
system responsiveness. In this context, ‘‘quiescence exit’’ is a
phase during which cells receive and accumulate signals prior
to committing to division. Our simulations show that when cell
division controlled by two independent characteristic times
(one before and one after the commitment point), it is far more
efficient than if cells are committed to divide within a fixed period
after sensing a signal. Control is further optimized when
quiescence exit is differentially regulated between LT- and ST-
HSCs. Thus, we propose that, even though its molecular bound-
aries remain to be defined, the duration of quiescence exit is a
biologically relevant time interval and the regulation of this dura-
tion inherently determines the dynamics of blood formation.
Overall our data point to a model of homeostasis where the
deeply quiescent state of LT-HSCs with a long duration of exit
from quiescence and the CDK6-primed G0 state of ST-HSCs
together provide a means to achieve efficient production of cells
from ST-HSCs while limiting the number of divisions that LT-
HSCs undergo.
Our data show that when the G0 exit delay is abolished due to
CDK6-enforced expression, the CDK6 EE LT-HSCs divide more
in repopulation assays, due to repeated rounds of accelerated
G0 exits. Accelerating exit from quiescence (at least via CDK6
EE) does not alter the balance between self-renewal and differ-
entiation or impair LT-HSC maintenance; rather, LT-HSCs ac-
quire a competitive advantage. This result is in striking contrast
with most situations of increased cycling presented in the litera-
ture (reviewed in Pietras et al., 2011) that cause impaired HSC
function. Interestingly, two of the most notable examples that in-
crease HSC division without damaging their long-term function
are p18 knockout (Yuan et al., 2004) and miR-126 knockdown
(Lechman et al., 2012). Because p18 is an Ink4 family member
known to repress CDK6, and because our recent data suggest
that miR-126 also targets CDK6 (E. Lechman and J.E.D., unpub-
lished data), it will be interesting to verify if the delay in G0 exit of
LT-HSCs is also suppressed in these models. Similarly, it needs
to be addressed how G0 exit duration is affected in cases
where increased cycling leads to HSC exhaustion. Indeed, why
increased cycling is generally associated with impaired LT-
HSC maintenance remains hypothetical (Orford and Scadden,C2008; Pietras et al., 2011; Rossi et al., 2012). In view of our
own results, we speculate that LT-HSCs may be pushed toward
differentiation at the expense of self-renewal if they shorten or
bypass phases of the cell cycle other than G0 exit, undergo
several rounds of division without returning to G0, or show imbal-
ances in key differentiation genes. Importantly, our experimental
and computational modeling data establish that fully functional
LT-HSCs can acquire competitive advantages in a purely kinetic
way. Such a phenomenon may be crucial during aging or in the
initial steps of leukemia, where clonal dominance may uniquely
arise as a consequence of the accelerated duration of G0
exit of LT-HSCs. Furthermore, recent work indicates that
PD033299, which selectively inhibits CDK6, might be efficacious
against multiple myeloma (Huang et al., 2012) and MLL-rear-
ranged AML (Placke et al., 2014), malignancies where the pre-
leukemic cell of origin is thought to be an HSC. Overall, the
finding that the duration of G0 exit is a highly relevant biological
parameter that controls stem cell pool dynamics warrants further
investigation of whether perturbation of stem cell-specific quies-
cence exit mechanisms represents an early step of malignancy.
EXPERIMENTAL PROCEDURES
CB Lineage Depletion
All CB samples were obtained with informed consent according to procedures
approved by the institutional review boards of the University Health Network,
Trillium, andCredit Valley Hospital. Mononuclear cells were obtained by centri-
fugation on Lymphoprepmedium (Stem Cell Technologies) and were depleted
of Lin+ cells (lineage depletion) by negative selection with the StemSep Human
Progenitor Cell Enrichment Kit according to themanufacturer’s protocol (Stem
Cell Technologies). Lin CB cells were stored at 150C.
Cell Preparation for Cell Sorting
Lin– cells were thawed by drop-wise addition of IMDM/DNase (100 mg/ml,
Roche) and were resuspended at 1 3 106 cells /ml. Cells were then stained
with the following (with all antibodies from BD, unless stated otherwise):
FITC—anti-CD45RA (1:50, 555488), PE—anti-CD90 (1:50, 555596), PECy5—
anti-CD49f (1:50, 551129), V450—anti-CD7 (1:33.3, 642916), PECy7—anti-
CD38 (1:100, 335790), APC—anti-CD10 (1:50, 340923), and APCCy7—anti-
CD34 (1:100, custommade by BD). Cells were sorted on FACS Aria III (Becton
Dickinson) or MoFlo (Beckman Coulter) sorters, consistently yielding >95%
purity. LT-HSCs were sorted based on the following markers: CD34+ CD38
CD45RA CD90+ CD49f+; ST-HSCs, based on CD34+ CD38 CD45RA
CD90 CD49f; and GMPs, based on CD34+ CD38 CD10 CD7 CD45RA+.
Single-Cell Experiments
Single LT-HSCs or ST-HSCs were sorted into 96-well round-bottom Nunc
plates in 100 ml of either high or low cytokines media, using FACS Aria III (Bec-
ton Dickinson). Cells were centrifuged 5 min at 4003 g and incubated at 37C
for 1 week. Cells were visualized and counted in each well twice a day using an
inverted microscope. High cytokine condition medium was by StemPro (Stem
Cell Technologies) supplemented with StemPro nutrients (Stem Cell Technol-
ogies), L-glutamine (GIBCO), Pen/Strep (GIBCO), human LDL (Stem Cell
Technologies, 50 ng/ml), and the following cytokines (all from Miltenyi): SCF
(100 ng/ml), Flt3L (20 ng/ml), TPO (100 ng/ml), EPO (3 units/ml), IL-6
(50 ng/ml), IL-3 (10 ng/ml), and GM-CSF (20 ng/ml). Low cytokine condition
medium was composed of X-VIVO 10 medium (BioWhittaker) supplemented
with 1% BSA (Roche), L-glutamine (GIBCO), Pen/Strep (GIBCO), and the
following cytokines (all from Miltenyi): SCF (100 ng/ml), Flt3L (100 ng/ml),
TPO (50 ng/ml), and IL7 (IL-7; 10 ng/ml).
Immunofluorescence
5 3 103 sorted LT-HSCs, ST-HSCs, or GMPs sorted by flow cytometry
were fixed ovre 10 min at room temperature (RT) in PBS and 2%ell Stem Cell 16, 302–313, March 5, 2015 ª2015 The Authors 311
paraformaldehyde, washed in PBS, distributed in 150 ml of PBS on polyly-
sine-coated slides, and incubated overnight in a humidified chamber at
RT. Cells were then permeabilized over 10 min in 0.2% Triton (SIGMA),
washed twice in PBS, and blocked over 20 min using 150 ml of PBS and
10% Goat Serum (Life Technologies). Cells were stained over 1 hr at RT in
150 ml of primary antibody solution in PBS and 10% Goat Serum with appro-
priate concentrations (CDK6, mouse monoclonal ab54576, Abcam, or CDK6
B-10, Santa Cruz sc7961; mouse IgG, Santa Cruz sc-2025; Cyclin D3 (C-16),
Santa Cruz: sc-182; rabbit IgG, Santa Cruz sc-2027). After cells were washed
twice in PBS, secondary antibody solution (goat anti-mouse Alexa 488, Life
Technologies, A11001) was added over 45 min at RT in the dark in 150 ml
PBS (10% Goat Serum) with the appropriate concentration (usually 1:500).
Slides were visualized on an Axioimager microscope and fluorescence
quantification and cell diameter measurements were performed with ImageJ
software.
Cell cycle analysis assay, xenotransplantation, the derivation of cell cycle
parameters, modeling, transcriptome studies, bioinformatics, qPCR, lentiviral
transduction, and mitochondrial mass measurements are reported in the
Supplemental Experimental Procedures.
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